JPWO2022244757A1 - - Google Patents
Info
- Publication number
- JPWO2022244757A1 JPWO2022244757A1 JP2023522667A JP2023522667A JPWO2022244757A1 JP WO2022244757 A1 JPWO2022244757 A1 JP WO2022244757A1 JP 2023522667 A JP2023522667 A JP 2023522667A JP 2023522667 A JP2023522667 A JP 2023522667A JP WO2022244757 A1 JPWO2022244757 A1 JP WO2022244757A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/44—Oxidoreductases (1)
- A61K38/446—Superoxide dismutase (1.15)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/543—Lipids, e.g. triglycerides; Polyamines, e.g. spermine or spermidine
- A61K47/544—Phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/548—Phosphates or phosphonates, e.g. bone-seeking
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0089—Oxidoreductases (1.) acting on superoxide as acceptor (1.15)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y115/00—Oxidoreductases acting on superoxide as acceptor (1.15)
- C12Y115/01—Oxidoreductases acting on superoxide as acceptor (1.15) with NAD or NADP as acceptor (1.15.1)
- C12Y115/01001—Superoxide dismutase (1.15.1.1)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Neurosurgery (AREA)
- Immunology (AREA)
- Neurology (AREA)
- Urology & Nephrology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Toxicology (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Inorganic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021083610 | 2021-05-18 | ||
| JP2021083610 | 2021-05-18 | ||
| PCT/JP2022/020473 WO2022244757A1 (ja) | 2021-05-18 | 2022-05-17 | 抗癌剤の投与に伴う障害を治療又は予防するための医薬組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JPWO2022244757A1 true JPWO2022244757A1 (cg-RX-API-DMAC7.html) | 2022-11-24 |
| JPWO2022244757A5 JPWO2022244757A5 (cg-RX-API-DMAC7.html) | 2023-12-13 |
| JP7504367B2 JP7504367B2 (ja) | 2024-06-24 |
Family
ID=84141593
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023522667A Active JP7504367B2 (ja) | 2021-05-18 | 2022-05-17 | 抗癌剤の投与に伴う障害を治療又は予防するための医薬組成物 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240261375A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4353251A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7504367B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR102843447B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN117279657A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022278242B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3220333A1 (cg-RX-API-DMAC7.html) |
| CO (1) | CO2023017275A2 (cg-RX-API-DMAC7.html) |
| MX (1) | MX428431B (cg-RX-API-DMAC7.html) |
| TW (1) | TWI867299B (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022244757A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2024411340A1 (en) | 2023-12-26 | 2026-06-18 | Ltt Bio-Pharma Co., Ltd. | Prophylactic and therapeutic agent for diseases caused by type i allergic reaction induced by anticancer agent |
| WO2025178511A1 (ru) * | 2024-02-21 | 2025-08-28 | Евгений Владимирович ГРИГОРЬЕВ | Применение супероксиддисмутазы 2 в качестве антиоксиданта в сверхмалых дозировках |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0653670B2 (ja) * | 1985-10-28 | 1994-07-20 | 日研フ−ド株式会社 | 化学療法剤の副作用低減化剤 |
| JPH04135485A (ja) * | 1990-09-28 | 1992-05-08 | Seikagaku Kogyo Co Ltd | 白金錯体及び抗腫瘍剤 |
| JP3232542B2 (ja) | 1993-01-08 | 2001-11-26 | 宇部興産株式会社 | ヒトCu,Zn型スーパーオキシドジスムターゼ誘導体及びその製造法 |
| JPH08208511A (ja) * | 1995-01-31 | 1996-08-13 | Samu Kenkyusho:Kk | 抗運動ニューロン疾患剤 |
| US6221848B1 (en) * | 1998-05-11 | 2001-04-24 | University Of Pittsburgh | Protection of the esophagus from chemotherapeutic or irradiation damage by gene therapy |
| US20020055467A1 (en) | 1998-07-06 | 2002-05-09 | Johansen Teit E. | Novel neurotrophic factors |
| JP2001002585A (ja) * | 1999-06-22 | 2001-01-09 | Ltt Kenkyusho:Kk | レシチン化スーパーオキシドジスムターゼ含有抗線維化剤 |
| JP3792487B2 (ja) | 1999-06-24 | 2006-07-05 | 株式会社Lttバイオファーマ | レシチン化スーパーオキシドジスムターゼ含有医薬組成物 |
| EP1292324A2 (en) | 2000-05-05 | 2003-03-19 | Novo Nordisk A/S | Critical illness neuropathy |
| JP2002080395A (ja) * | 2000-08-31 | 2002-03-19 | Ltt Institute Co Ltd | 心筋傷害処置剤 |
| WO2004065410A2 (en) | 2003-01-21 | 2004-08-05 | Genervon Biopharmaceuticals Llc | Mntf peptides and compositions and methods of use |
| KR101183856B1 (ko) * | 2004-10-12 | 2012-09-19 | 가부시키가이샤 엘티티 바이오파마 | 레시틴화 수퍼옥사이드 디스뮤타아제 조성물 및 그 제조방법 |
| WO2006050211A2 (en) | 2004-10-28 | 2006-05-11 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Peripherally delivered glutamic acid decarboxylase gene therapy for spinal cord injury pain |
| JP2006169128A (ja) | 2004-12-13 | 2006-06-29 | Ltt Bio-Pharma Co Ltd | 熱傷治療剤 |
| JP4867540B2 (ja) | 2006-09-20 | 2012-02-01 | 日本精工株式会社 | 無段変速装置 |
| CA2671668A1 (en) * | 2006-12-19 | 2008-06-26 | Ltt Bio-Pharma Co., Ltd. | Therapeutic composition for interstitial pheumonia |
| JP5459827B2 (ja) | 2009-03-13 | 2014-04-02 | 株式会社Lttバイオファーマ | 慢性閉塞性肺疾患改善剤 |
| JP6231386B2 (ja) | 2010-11-09 | 2017-11-15 | ノヴォ ノルディスク アー/エス | リンカーを有する二重アシル化されたglp−1誘導体 |
| BR112014016497B1 (pt) | 2012-01-05 | 2021-02-23 | Pledpharma Ab | complexos de metal misturados, composição farmacêutica compreendendo os mesmos, métodos de produção e uso |
| JP6545926B2 (ja) * | 2012-11-30 | 2019-07-17 | 株式会社ナノエッグ | 手足症候群治療用組成物 |
| KR20170036753A (ko) | 2014-07-31 | 2017-04-03 | 글락소스미스클라인 인털렉츄얼 프로퍼티 디벨로프먼트 리미티드 | 화학요법 유도된 말초 신경병증 (cipn)의 예방 및/또는 치료를 위한 cxcr2 길항제의 용도 |
| EP2985036A3 (en) | 2014-08-14 | 2016-03-09 | Fraunhofer Gesellschaft zur Förderung der angewandten Forschung e.V. | CYP2J2 antagonists in the treatment of pain |
| JP6851639B2 (ja) | 2015-07-16 | 2021-03-31 | ゾミクス バイオファーマ, インコーポレイテッド | プラチナ薬剤の毒性の予防方法 |
| JP6650612B2 (ja) | 2015-10-06 | 2020-02-19 | パナソニックIpマネジメント株式会社 | 照明制御装置及び照明システム |
-
2022
- 2022-05-17 MX MX2023013777A patent/MX428431B/es unknown
- 2022-05-17 EP EP22804668.6A patent/EP4353251A4/en active Pending
- 2022-05-17 AU AU2022278242A patent/AU2022278242B2/en active Active
- 2022-05-17 JP JP2023522667A patent/JP7504367B2/ja active Active
- 2022-05-17 US US18/560,442 patent/US20240261375A1/en active Pending
- 2022-05-17 WO PCT/JP2022/020473 patent/WO2022244757A1/ja not_active Ceased
- 2022-05-17 KR KR1020237038088A patent/KR102843447B1/ko active Active
- 2022-05-17 CA CA3220333A patent/CA3220333A1/en active Pending
- 2022-05-17 CN CN202280033165.1A patent/CN117279657A/zh active Pending
- 2022-05-18 TW TW111118516A patent/TWI867299B/zh active
-
2023
- 2023-12-14 CO CONC2023/0017275A patent/CO2023017275A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2022278242B2 (en) | 2024-11-14 |
| MX2023013777A (es) | 2023-12-04 |
| CA3220333A1 (en) | 2022-11-24 |
| BR112023024140A2 (pt) | 2024-02-06 |
| KR102843447B1 (ko) | 2025-08-06 |
| EP4353251A1 (en) | 2024-04-17 |
| CN117279657A (zh) | 2023-12-22 |
| TWI867299B (zh) | 2024-12-21 |
| CO2023017275A2 (es) | 2023-12-20 |
| KR20240008844A (ko) | 2024-01-19 |
| JP7504367B2 (ja) | 2024-06-24 |
| AU2022278242A1 (en) | 2023-11-30 |
| WO2022244757A1 (ja) | 2022-11-24 |
| TW202313100A (zh) | 2023-04-01 |
| MX428431B (es) | 2025-11-13 |
| EP4353251A4 (en) | 2025-05-14 |
| US20240261375A1 (en) | 2024-08-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN305730742S (zh) | 茶台(yc-19-ct-669) | |
| CN305722205S (zh) | 家具快速制作连接器 | |
| CN305695498S (zh) | 酒瓶 | |
| CN305720176S (zh) | 椅子 | |
| CN305739436S (zh) | 茶几(qj06) | |
| CN305663445S (zh) | 型材(xf19—e16960) | |
| CN305721245S (zh) | 奶瓶 | |
| CN305698768S (zh) | 超市收银称重标识灯箱(d) | |
| CN305672332S (zh) | 坐便器(卡拉) | |
| CN305725082S (zh) | 用于电脑的内容管理平台图形用户界面 | |
| CN305660841S (zh) | 拖挂车 | |
| CN305738033S (zh) | 便携式冲奶机 | |
| CN305696406S (zh) | 吊坠(鼠你花不完) | |
| CN305736637S (zh) | 便携式内衣裤烘干消毒机 | |
| CN305709009S (zh) | 玻璃钢环保节能风机 | |
| CN305672837S (zh) | 灯笼飘带(led) | |
| CN305658513S (zh) | 花架(一帆风顺) | |
| CN305696220S (zh) | 太赫兹安检仪 | |
| CN305562250S (zh) | 型材(背发光大弧边角sl-s1031) | |
| CN305549458S (zh) | 茶具(明心盏) | |
| CN305531014S (zh) | 电子琴 | |
| CN305666150S (zh) | 圆桌(golden table) | |
| CN305562925S (zh) | 按摩器(鱼嘴吸吮) | |
| CN305554442S (zh) | 懒人风扇(脖子) | |
| CN305532896S (zh) | 宠物包 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20231124 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20231124 |
|
| A871 | Explanation of circumstances concerning accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A871 Effective date: 20231124 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20231226 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240219 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20240514 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20240531 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7504367 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |